International audienceTwenty four aminoporphyrin derivatives have been tested in vitro for their antibacterial photoactivity against Escherichia coli and Staphylococcus aureus. Two of these compounds, bearing polyamine units, exhibited a significant activity especially against Gram-negative bacteria (E. coli).Twenty four aminoporphyrin derivatives have been tested in vitro for their antibacterial photoactivity against Escherichia coli and Staphylococcus aureus. Two of these compounds, bearing polyamine units (17–18) exhibited a significant activity especially against gram-negative bacteria. For 17, 18: R1=R2=R3=R4=H, a=CH3, b=CHCH2 and c=(CH2)2COspermidine for 17, c=(CH2)2COspermine for 18
Antimicrobial photodynamic therapy (PDT) utilizing porphyrins has emerged as a possible ancillary tr...
WOS: 000448197700008PubMed ID: 30353469y Methicillin resistant Staphylococcus aureus (MRSA) with mul...
Photodynamic inactivation (PDI) is a non-antibiotic option for the treatment of infectious diseases....
The authors studied the in vitro antibacterial activity of the photo-activated porphyrin meso-tri(N-...
Due mainly to the extensive use of antibiotics, the spread of multiresistant bacterial strains is on...
New porphyrin–Schiff base conjugates bearing one (6) and two (7) basic amino groups were synthesized...
Photodynamic inactivation (PDI) of microorganisms is successfully applied against Gram (+) microorga...
The emergence of microbial resistance to many of the major classes of antimicrobial drugs is becomin...
Photodynamic antimicrobial chemotherapy (PACT), as a novel and effective therapeutic modality to era...
Porphyrines and their derivatives application, commonly associated with Photodynamic Therapy (PDT), ...
International audienceAnionic, neutral and cationic amino porphyrins were synthesized as precursors ...
Widespread antibiotic resistance demands new strategies for fighting infections. Porphyrin-based com...
Medical Technologies National Congress (TIPTEKNO) -- OCT 12-14, 2017 -- TRABZON, TURKEYWOS: 00042764...
Antimicrobial PhotoDynamic Therapy (APDT) represents a very promising strategy, particularly for t...
PubMed: 318940202-s2.0-85077385635In this study, it was aimed to investigate the antibacterial activ...
Antimicrobial photodynamic therapy (PDT) utilizing porphyrins has emerged as a possible ancillary tr...
WOS: 000448197700008PubMed ID: 30353469y Methicillin resistant Staphylococcus aureus (MRSA) with mul...
Photodynamic inactivation (PDI) is a non-antibiotic option for the treatment of infectious diseases....
The authors studied the in vitro antibacterial activity of the photo-activated porphyrin meso-tri(N-...
Due mainly to the extensive use of antibiotics, the spread of multiresistant bacterial strains is on...
New porphyrin–Schiff base conjugates bearing one (6) and two (7) basic amino groups were synthesized...
Photodynamic inactivation (PDI) of microorganisms is successfully applied against Gram (+) microorga...
The emergence of microbial resistance to many of the major classes of antimicrobial drugs is becomin...
Photodynamic antimicrobial chemotherapy (PACT), as a novel and effective therapeutic modality to era...
Porphyrines and their derivatives application, commonly associated with Photodynamic Therapy (PDT), ...
International audienceAnionic, neutral and cationic amino porphyrins were synthesized as precursors ...
Widespread antibiotic resistance demands new strategies for fighting infections. Porphyrin-based com...
Medical Technologies National Congress (TIPTEKNO) -- OCT 12-14, 2017 -- TRABZON, TURKEYWOS: 00042764...
Antimicrobial PhotoDynamic Therapy (APDT) represents a very promising strategy, particularly for t...
PubMed: 318940202-s2.0-85077385635In this study, it was aimed to investigate the antibacterial activ...
Antimicrobial photodynamic therapy (PDT) utilizing porphyrins has emerged as a possible ancillary tr...
WOS: 000448197700008PubMed ID: 30353469y Methicillin resistant Staphylococcus aureus (MRSA) with mul...
Photodynamic inactivation (PDI) is a non-antibiotic option for the treatment of infectious diseases....